Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-020162

EVP, Growth Markets Commercial sold 320 shares at $16.64 ($5,326)

  • EVP, Growth Markets Commercial acquired 872 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Nazzi Gianfranco · EVP, Growth Markets Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-17 Exercise or conversion : show line 1 in the form +872 9,322.36 D
2019-03-18 Sale : show line 2 in the form −320 $16.64 $5,326 9,002.36 D
Open-market sales · 320 sh · avg $16.64 · $5,326

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-17 Exercise or conversion : show line 3 in the form Restricted Share Units −872 874 D
Loading xslF345X03/doc4.xml…